PULMONX CORPORATION (LUNG) Operating margin 2018–2025
PULMONX CORPORATION (LUNG) operating margin by fiscal year — reported operating income divided by reported revenue.
-59.3%FY2025 · since FY2018: -75.2% → -59.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -59.3% | +9.6 pp |
| FY2024 | -68.9% | +21.3 pp |
| FY2023 | -90.2% | +19.1 pp |
| FY2022 | -109.3% | -11.6 pp |
| FY2021 | -97.7% | +1.1 pp |
| FY2020 | -98.8% | -44.0 pp |
| FY2019 | -54.7% | +20.5 pp |
| FY2018 | -75.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice